相关实验视频
Updated: Jun 5, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.0K
无形皮肤炎与炎症性肠病风险之间的关联:长度研究的元分析
Pengfei Yu1, Li Lin1, Kaiyuan Xue1
1The First Clinical College of Heilongjiang University of Traditional Chinese Medicine Harbin People's Republic of China.
JGH open : an open access journal of gastroenterology and hepatology
|December 16, 2024
概括
亚托皮性皮肤炎 (AD) 显著增加患炎症性肠病 (IBD) 的风险,包括克罗恩病 (CD) 和性结肠炎 (UC). 这一发现突显了皮肤和肠道炎症之间的关键联系.
科学领域:
- 皮肤病学和胃肠病学
- 流行病学 流行病学
- 系统性炎症性疾病系统性炎症性疾病
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病.
- 新出现的证据表明,阿尔茨海默病与其他炎症性疾病之间存在潜在联系.
- 阿尔茨海默病和炎症性肠病 (IBD) 之间的关系需要进一步调查.
研究的目的:
- 系统地审查和元分析纵向研究.
- 确定亚托皮性皮肤炎 (AD) 是否与炎症性肠病 (IBD) 的风险增加有关.
- 调查克罗恩病 (CD) 和性结肠炎 (UC) 的特定风险.
主要方法:
- 在主要数据库 (PubMed,CENTRAL,Embase,Scopus,Web of Science) 进行全面的文献搜索,截至2024年4月.
- 包括八项回顾性队列研究,涉及超过6100万参与者.
- 进行元分析和聚合分析,以评估AD与IBD,CD和UC之间的关联.
主要成果:
- 分析显示,阿尔茨海默病患者的IBD风险显著增加 (OR: 1.37).
- 艾滋病被确定为克罗恩病 (OR: 1.51) 和性结肠炎 (OR: 1.33) 的重要危险因素.
- 敏感性分析证实了这些发现的可靠性.
结论:
- 亚托皮性皮肤炎 (AD) 与患上炎症性肠病 (IBD) 的风险显著增加有关.
- 这些发现表明,AD增加了IBD两种主要亚型的风险:克罗恩病 (CD) 和性结肠炎 (UC).
- 这项研究强调了亚托皮性皮炎的全身性质及其对胃肠道健康的影响.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183
Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Irritable Bowel Syndrome I: Introduction
244
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
244
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111

